Skip to main content
. 2015 Mar 7;21(4):935–940. doi: 10.1007/s12253-015-9922-y

Table 3.

Distribution of RAD51 genotype and allele frequencies in patients with triple- negative breast cancer and in control groups

Patients with TNBC n = 70 Controls n = 70
172G/T Number (%) Number (%) OR (95 % CI)a p b
G/G 17 24 20 29 1.00 Ref
G/T 11 16 40 57 0.32 (0.13–0.82) 0.028
T/T 42 60 10 14 4.94 (1.91–12.71) 0.001
G 45 32 80 57 1.00 Ref
T 95 68 60 43 2.81 (1.72–4.58) <.0001

Data in bold font are statistically significant

aCrude odds ratio (OR), 95 % CI = confidence interval at 95 %

bChi square